Augmedix, Inc.
AUGX · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $13,664 | $13,471 | $12,680 | $11,767 |
| % Growth | 1.4% | 6.2% | 7.8% | – |
| Cost of Goods Sold | $7,209 | $7,130 | $6,434 | $5,937 |
| Gross Profit | $6,455 | $6,341 | $6,246 | $5,830 |
| % Margin | 47.2% | 47.1% | 49.3% | 49.5% |
| R&D Expenses | $4,418 | $3,833 | $2,940 | $2,936 |
| G&A Expenses | $7,013 | $5,347 | $4,907 | $4,568 |
| SG&A Expenses | $10,762 | $8,910 | $7,653 | $7,297 |
| Sales & Mktg Exp. | $3,749 | $3,563 | $2,746 | $2,729 |
| Other Operating Expenses | $0 | -$64 | $94 | -$4 |
| Operating Expenses | $15,180 | $12,743 | $10,593 | $10,233 |
| Operating Income | -$8,725 | -$6,402 | -$4,347 | -$4,403 |
| % Margin | -63.9% | -47.5% | -34.3% | -37.4% |
| Other Income/Exp. Net | $361 | -$177 | -$167 | $80 |
| Pre-Tax Income | -$8,364 | -$6,579 | -$4,515 | -$4,407 |
| Tax Expense | $86 | -$80 | -$24 | $0 |
| Net Income | -$8,450 | -$6,499 | -$4,491 | -$4,407 |
| % Margin | -61.8% | -48.2% | -35.4% | -37.5% |
| EPS | -0.16 | -0.12 | -0.092 | -0.097 |
| % Growth | -33.3% | -31% | 5.4% | – |
| EPS Diluted | -0.16 | -0.12 | -0.092 | -0.097 |
| Weighted Avg Shares Out | 53,387 | 53,059 | 49,021 | 45,521 |
| Weighted Avg Shares Out Dil | 53,387 | 53,059 | 49,021 | 45,521 |
| Supplemental Information | – | – | – | – |
| Interest Income | $410 | $503 | $384 | $288 |
| Interest Expense | $639 | $616 | $645 | $642 |
| Depreciation & Amortization | $416 | $439 | $306 | $463 |
| EBITDA | -$7,309 | -$5,524 | -$3,564 | -$3,218 |
| % Margin | -53.5% | -41% | -28.1% | -27.3% |